Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2015 4
2016 10
2017 14
2018 17
2019 18
2020 26
2021 29
2022 16
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 34330809

110 results

Results by year

Filters applied: . Clear all
Page 1
Correlation of Lesional Uptake Parameters and Ratios with miPSMA Score and Estimating Normal Physiologic Concentration: An Exploratory Analysis in Metastatic Castration-Resistant Prostatic Carcinoma Patients with 68Ga-PSMA-11 PET/CT.
Kalshetty A, Menon B, Rakshit S, Bhattacharjee A, Basu S. Kalshetty A, et al. J Nucl Med Technol. 2021 Sep;49(3):235-240. doi: 10.2967/jnmt.120.261289. Epub 2021 Jul 9. J Nucl Med Technol. 2021. PMID: 34244223 Free article.
Tumor Sink Effect in 68Ga-PSMA-11 PET: Myth or Reality?
Gafita A, Wang H, Robertson A, Armstrong WR, Zaum R, Weber M, Yagubbayli F, Kratochwil C, Grogan TR, Nguyen K, Navarro F, Esfandiari R, Rauscher I, Menze B, Elashoff D, Delpassand ES, Herrmann K, Czernin J, Hofman MS, Calais J, Fendler WP, Eiber M. Gafita A, et al. J Nucl Med. 2022 Feb;63(2):226-232. doi: 10.2967/jnumed.121.261906. Epub 2021 May 28. J Nucl Med. 2022. PMID: 34049987 Free PMC article.
How accurate is 68Gallium-prostate specific membrane antigen positron emission tomography / computed tomography (68Ga-PSMA PET/CT) on primary lymph node staging before radical prostatectomy in intermediate and high risk prostate cancer? A study of patient- and lymph node- based analyses.
Erdem S, Simsek DH, Degirmenci E, Aydin R, Bagbudar S, Ozluk Y, Sanli Y, Sanli O, Ozcan F. Erdem S, et al. Urol Oncol. 2022 Jan;40(1):6.e1-6.e9. doi: 10.1016/j.urolonc.2021.07.006. Epub 2021 Aug 13. Urol Oncol. 2022. PMID: 34400066
110 results